Literature DB >> 27921121

A 4D ultrasound real-time tracking system for external beam radiotherapy of upper abdominal lesions under breath-hold.

Dwi Seno Kuncoro Sihono1, Lena Vogel2, Christel Weiß3, Johannes Thölking2, Frederik Wenz2, Frank Lohr2,4, Judit Boda-Heggemann2, Hansjörg Wertz2.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate a novel four-dimensional (4D) ultrasound (US) tracking system for external beam radiotherapy of upper abdominal lesions under computer-controlled deep-inspiration breath-hold (DIBH).
MATERIALS AND METHODS: The tracking accuracy of the research 4D US system was evaluated using two motion phantoms programmed with sinusoidal and breathing patterns to simulate free breathing and DIBH. Clinical performance was evaluated with five healthy volunteers. US datasets were acquired in computer-controlled DIBH with varying angular scanning angles. Tracked structures were renal pelvis (spherical structure) and portal/liver vein branches (non-spherical structure). An external marker was attached to the surface of both phantoms and volunteers as a secondary object to be tracked by an infrared camera for comparison.
RESULTS: Phantom measurements showed increased accuracy of US tracking with decreasing scanning range/increasing scanning frequency. The probability of lost tracking was higher for small scanning ranges (43.09% for 10° and 13.54% for 20°).The tracking success rates in healthy volunteers during DIBH were 93.24 and 89.86% for renal pelvis and portal vein branches, respectively. There was a strong correlation between marker motion and US tracking for the majority of analyzed breath-holds: 84.06 and 88.41% of renal pelvis target results and 82.26 and 91.94% of liver vein target results in anteroposterior and superoinferior directions, respectively; Pearson's correlation coefficient was between 0.71 and 0.99.
CONCLUSION: The US system showed a good tracking performance in 4D motion phantoms. The tracking capability of surrogate structures for upper abdominal lesions in DIBH fulfills clinical requirements. Further investigation in a larger cohort of patients is underway.

Entities:  

Keywords:  Intrafractional tracking; Radiotherapy, image-guided; Stereotactic body radiotherapy (SBRT); Ultrasound; Upper abdomen

Mesh:

Year:  2016        PMID: 27921121     DOI: 10.1007/s00066-016-1076-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  23 in total

1.  The use of active breathing control (ABC) to reduce margin for breathing motion.

Authors:  J W Wong; M B Sharpe; D A Jaffray; V R Kini; J M Robertson; J S Stromberg; A A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

2.  Active breathing control in combination with ultrasound imaging: a feasibility study of image guidance in stereotactic body radiation therapy of liver lesions.

Authors:  Esther Bloemen-van Gurp; Skadi van der Meer; Janet Hendry; Jeroen Buijsen; Peter Visser; Davide Fontanarosa; Martin Lachaine; Guido Lammering; Frank Verhaegen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-08       Impact factor: 7.038

Review 3.  Motion management in gastrointestinal cancers.

Authors:  Hassan Abbas; Bryan Chang; Zhe Jay Chen
Journal:  J Gastrointest Oncol       Date:  2014-06

4.  Multiple breath-hold CBCT for online image guided radiotherapy of lung tumors: simulation with a dynamic phantom and first patient data.

Authors:  Judit Boda-Heggemann; Jens Fleckenstein; Frank Lohr; Hansjörg Wertz; Mohammed Nachit; Manuel Blessing; Dzimitry Stsepankou; Iris Löb; Beate Küpper; Anthony Kavanagh; Vibeke N Hansen; Michael Brada; Frederik Wenz; Helen McNair
Journal:  Radiother Oncol       Date:  2011-02-21       Impact factor: 6.280

5.  Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer.

Authors:  Twyla R Willoughby; Patrick A Kupelian; Jean Pouliot; Katsuto Shinohara; Michelle Aubin; Mack Roach; Lisa L Skrumeda; James M Balter; Dale W Litzenberg; Scott W Hadley; John T Wei; Howard M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

6.  Real-time monitoring and control on deep inspiration breath-hold for lung cancer radiotherapy--combination of ABC and external marker tracking.

Authors:  Victy Y W Wong; Stewart Y Tung; Alice W Y Ng; Francis A S Li; Joyce O Y Leung
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

7.  Liver motion during cone beam computed tomography guided stereotactic body radiation therapy.

Authors:  Justin C Park; Sung Ho Park; Jong Hoon Kim; Sang Min Yoon; Si Yeol Song; Zhaowei Liu; Bongyong Song; Kevin Kauweloa; Matthew J Webster; Ajay Sandhu; Loren K Mell; Steve B Jiang; Arno J Mundt; William Y Song
Journal:  Med Phys       Date:  2012-10       Impact factor: 4.071

8.  Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer.

Authors:  Shyam K Tanguturi; Yulia Lyatskaya; Yuhui Chen; Paul J Catalano; Ming Hui Chen; Wee-Pin Yeo; Alex Marques; Linh Truong; Mary Yeh; Lawrence Orlina; Julia S Wong; Rinaa S Punglia; Jennifer R Bellon
Journal:  Pract Radiat Oncol       Date:  2015-07-28

9.  Clinical evaluation of a commercial surface-imaging system for patient positioning in radiotherapy.

Authors:  F Stieler; F Wenz; D Scherrer; M Bernhardt; F Lohr
Journal:  Strahlenther Onkol       Date:  2012-11-10       Impact factor: 3.621

10.  Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.

Authors:  Judit Boda-Heggemann; Dietmar Dinter; Christel Weiss; Anian Frauenfeld; Kerstin Siebenlist; Ulrike Attenberger; Martine Ottstadt; Frank Schneider; Ralf-Dieter Hofheinz; Frederik Wenz; Frank Lohr
Journal:  Radiat Oncol       Date:  2012-06-18       Impact factor: 3.481

View more
  1 in total

1.  Performance of gimbal-based dynamic tumor tracking for treating liver carcinoma.

Authors:  Marc Ziegler; Tobias Brandt; Sebastian Lettmaier; Rainer Fietkau; Christoph Bert
Journal:  Radiat Oncol       Date:  2018-12-05       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.